Validation pour Ingenuity306

vers la météo de la validation par utilisateur

Ingenuity306

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 75 - PMID ?

In SP dermal fibroblasts , advanced glycation endproducts SP serum NODE causes little or no change in expression of SP NODE rP1 [NODE] mRNA .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

                       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                 
                       |                                +----------------------------------SUBJ:V-N---------------------------------+-----------OBJ:V-N-----------+   
                       |                                +------------OBJ:V-N------------+                                           |       +----MOD_ATT:N-ADJ----+   
       +-MOD_ATT:N-ADJ-+            +---MOD_ATT:N-ADJ---+         +MOD_ATT:N-ADJ+       +----------COMP:V-N(in)---------+           |       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+         |     +MOD_ATT+SUBJ:V-+------OBJ:V-N------+           +MOD_PO+    |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |                   |           |      |    |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,endproducts)
SUBJ:V-N (cause,__NODE__)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
MOD_POST:N-ADJ (expression,of)
COMP:V-N(In) (__SP__,fibroblast)
SUBJ:V-N (__SP__,endproducts)
OBJ:V-N (__SP__,mRNA)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 1

                       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                 
                       |                                +----------------------------------SUBJ:V-N---------------------------------+-----------OBJ:V-N-----------+   
                       |                                +------------OBJ:V-N------------+                                           |       +----MOD_ATT:N-ADJ----+   
       +-MOD_ATT:N-ADJ-+            +---MOD_ATT:N-ADJ---+         +MOD_ATT:N-ADJ+       +----------COMP:V-N(in)---------+           |       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+         |     +MOD_ATT+SUBJ:V-+------OBJ:V-N------+           +MOD_PO+    |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |                   |           |      |    |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,endproducts)
SUBJ:V-N (cause,__NODE__)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
MOD_POST:N-ADJ (expression,of)
COMP:V-N(In) (__SP__,fibroblast)
SUBJ:V-N (__SP__,endproducts)
OBJ:V-N (__SP__,mRNA)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 2

                       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                 
                       |                                +----------------------------------SUBJ:V-N---------------------------------+-----------OBJ:V-N-----------+   
                       |                                +------------OBJ:V-N------------+----------COMP:V-N(in)---------+           |       +----MOD_ATT:N-ADJ----+   
       +-MOD_ATT:N-ADJ-+            +---MOD_ATT:N-ADJ---+         +MOD_ATT:N-ADJ+       +------OBJ:V-N------+           |           |       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+         |     +MOD_ATT+SUBJ:V-+OBJ:V-+            |           +MOD_PO+    |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |      |    |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,endproducts)
SUBJ:V-N (cause,__NODE__)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
MOD_POST:N-ADJ (expression,of)
COMP:V-N(In) (__SP__,fibroblast)
SUBJ:V-N (__SP__,endproducts)
OBJ:V-N (__SP__,mRNA)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 3

                                                                                                                        +---------------COMP:N-N(of)--------------+   
                                                                  +---------------------COMP:V-N(in)--------------------+           +--------MOD_ATT:N-ADJ--------+   
                       +---------------COMP:V-N(In)---------------+-----------------OBJ:V-N-----------------+           |           |       +----MOD_ATT:N-ADJ----+   
       +-MOD_ATT:N-ADJ-+            +---MOD_ATT:N-ADJ---+         |     +----OBJ:V-N----+                   |           |           |       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+-SUBJ:V-N+OBJ:V+       +SUBJ:V-+MOD:V-+            |           |           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
COMP:V-N(In) (__SP__,fibroblast)
SUBJ:V-N (__SP__,endproducts)
OBJ:V-N (__SP__,serum)
OBJ:V-N (__SP__,change)
COMP:V-N(in) (__SP__,expression)
OBJ:V-N (cause,serum)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 4

                                                                                                                        +---------------COMP:N-N(of)--------------+   
                                                                  +---------------------COMP:V-N(in)--------------------+           +--------MOD_ATT:N-ADJ--------+   
                       +---------------COMP:V-N(In)---------------+-----------------OBJ:V-N-----------------+           |           |       +----MOD_ATT:N-ADJ----+   
       +-MOD_ATT:N-ADJ-+            +---MOD_ATT:N-ADJ---+         |     +----OBJ:V-N----+                   |           |           |       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+-SUBJ:V-N+OBJ:V+       +SUBJ:V-+MOD:V-+            |           |           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
COMP:V-N(In) (__SP__,fibroblast)
SUBJ:V-N (__SP__,endproducts)
OBJ:V-N (__SP__,serum)
OBJ:V-N (__SP__,change)
COMP:V-N(in) (__SP__,expression)
OBJ:V-N (cause,serum)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 5

                                                                                                                        +---------------COMP:N-N(of)--------------+   
                                                        +--------------------------COMP:V-N(in)-------------------------+           +--------MOD_ATT:N-ADJ--------+   
                                                        +----------------------OBJ:V-N----------------------+           |           |       +----MOD_ATT:N-ADJ----+   
       +-MOD_ATT:N-ADJ-+----------COMP:V-N(In)----------+----OBJ:V-N----+----OBJ:V-N----+                   |           |           |       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+-SUBJ:V-N-+         +MOD_A+       +SUBJ:V-+MOD:V-+            |           |           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
COMP:V-N(In) (endproducts,fibroblast)
SUBJ:V-N (endproducts,glycation)
OBJ:V-N (endproducts,serum)
OBJ:V-N (endproducts,change)
COMP:V-N(in) (endproducts,expression)
MOD_ATT:N-ADJ (serum,__SP__)
OBJ:V-N (cause,serum)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 6

                                                                                                                        +---------------COMP:N-N(of)--------------+   
                                                        +--------------------------COMP:V-N(in)-------------------------+           +--------MOD_ATT:N-ADJ--------+   
                                                        +----------------------OBJ:V-N----------------------+           |           |       +----MOD_ATT:N-ADJ----+   
       +-MOD_ATT:N-ADJ-+----------COMP:V-N(In)----------+         +-------OBJ:V-N-------+                   |           |           |       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+-SUBJ:V-N-+-OBJ:V-N-+     +MOD_ATT+SUBJ:V-+MOD:V-+            |           |           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
COMP:V-N(In) (endproducts,fibroblast)
SUBJ:V-N (endproducts,glycation)
OBJ:V-N (endproducts,__SP__)
OBJ:V-N (endproducts,change)
COMP:V-N(in) (endproducts,expression)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 7

                       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                 
                       |                                +----------------------------------SUBJ:V-N---------------------------------+-----------OBJ:V-N-----------+   
                       |                                +------------OBJ:V-N------------+                                           |       +----MOD_ATT:N-ADJ----+   
       +-MOD_ATT:N-ADJ-+            +---MOD_ATT:N-ADJ---+         +MOD_ATT:N-ADJ+       |                                           |       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+         |     +MOD_ATT+SUBJ:V-+------OBJ:V-N------+COMP:N-N(in+MOD_PO+    |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |                   |           |      |    |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,endproducts)
SUBJ:V-N (cause,__NODE__)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
MOD_POST:N-ADJ (expression,of)
COMP:V-N(In) (__SP__,fibroblast)
SUBJ:V-N (__SP__,endproducts)
OBJ:V-N (__SP__,mRNA)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 8

                       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                 
                       |                                +----------------------------------SUBJ:V-N---------------------------------+-----------OBJ:V-N-----------+   
                       |                                +------------OBJ:V-N------------+                                           |       +----MOD_ATT:N-ADJ----+   
       +-MOD_ATT:N-ADJ-+            +---MOD_ATT:N-ADJ---+         +MOD_ATT:N-ADJ+       |                   +--MOD_POST:N-ADJ--+    |       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+         |     +MOD_ATT+SUBJ:V-+------OBJ:V-N------+COMP:N-N(in+      |    |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |                   |           |      |    |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,endproducts)
SUBJ:V-N (cause,__NODE__)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
MOD_POST:N-ADJ (change,of)
COMP:V-N(In) (__SP__,fibroblast)
SUBJ:V-N (__SP__,endproducts)
OBJ:V-N (__SP__,mRNA)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 9

                       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                 
                       |                                +----------------------------------SUBJ:V-N---------------------------------+-----------OBJ:V-N-----------+   
                       |                                +------------OBJ:V-N------------+                                           |       +----MOD_ATT:N-ADJ----+   
       +-MOD_ATT:N-ADJ-+            +---MOD_ATT:N-ADJ---+         +MOD_ATT:N-ADJ+       |                   +--MOD_POST:N-ADJ--+    |       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+         |     +MOD_ATT+SUBJ:V-+------OBJ:V-N------+COMP:N-N(in+      |    |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |                   |           |      |    |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,endproducts)
SUBJ:V-N (cause,__NODE__)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
MOD_POST:N-ADJ (change,of)
COMP:V-N(In) (__SP__,fibroblast)
SUBJ:V-N (__SP__,endproducts)
OBJ:V-N (__SP__,mRNA)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 10

                       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                 
                       |                                +----------------------------------SUBJ:V-N---------------------------------+-----------OBJ:V-N-----------+   
                       |                                +------------OBJ:V-N------------+      +------COMP:N-N(in)------+           |       +----MOD_ATT:N-ADJ----+   
       +-MOD_ATT:N-ADJ-+            +---MOD_ATT:N-ADJ---+         +MOD_ATT:N-ADJ+       +------OBJ:V-N------+           |           |       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+         |     +MOD_ATT+SUBJ:V-+OBJ:V-+            +COMP:N-N(in+MOD_PO+    |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |      |    |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,endproducts)
SUBJ:V-N (cause,__NODE__)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
MOD_POST:N-ADJ (expression,of)
COMP:V-N(In) (__SP__,fibroblast)
SUBJ:V-N (__SP__,endproducts)
OBJ:V-N (__SP__,mRNA)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 11

                       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                 
                       |                                +----------------------------------SUBJ:V-N---------------------------------+-----------OBJ:V-N-----------+   
                       |                                +------------OBJ:V-N------------+      +------COMP:N-N(in)------+           |       +----MOD_ATT:N-ADJ----+   
       +-MOD_ATT:N-ADJ-+            +---MOD_ATT:N-ADJ---+         +MOD_ATT:N-ADJ+       +------OBJ:V-N------+           |           |       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+         |     +MOD_ATT+SUBJ:V-+OBJ:V-+            +COMP:N-N(in+MOD_PO+    |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |      |    |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,endproducts)
SUBJ:V-N (cause,__NODE__)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
MOD_POST:N-ADJ (expression,of)
COMP:V-N(In) (__SP__,fibroblast)
SUBJ:V-N (__SP__,endproducts)
OBJ:V-N (__SP__,mRNA)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 12

                       +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                 
                       |                                +----------------------------------SUBJ:V-N---------------------------------+                                 
                       |                                |                                      +---------MOD_POST:N-ADJ--------+    +-----------OBJ:V-N-----------+   
                       |                                +------------OBJ:V-N------------+      +------COMP:N-N(in)------+      |    |       +----MOD_ATT:N-ADJ----+   
       +-MOD_ATT:N-ADJ-+            +---MOD_ATT:N-ADJ---+         +MOD_ATT:N-ADJ+       +------OBJ:V-N------+--MOD_POST:N-ADJ--+    |       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+         |     +MOD_ATT+SUBJ:V-+OBJ:V-+            +COMP:N-N(in+      |    |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |      |    |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,endproducts)
SUBJ:V-N (cause,__NODE__)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
MOD_POST:N-ADJ (little,of)
COMP:N-N(in) (change,expression)
MOD_POST:N-ADJ (change,of)
COMP:V-N(In) (__SP__,fibroblast)
SUBJ:V-N (__SP__,endproducts)
OBJ:V-N (__SP__,mRNA)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 13

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                                +--------------------------------------SUBJ:V-N-------------------------------------+                         
                       |                                +------------OBJ:V-N------------+                                                   +-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            +---MOD_ATT:N-ADJ---+         +MOD_ATT:N-ADJ+       |                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,endproducts)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,endproducts)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 14

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                                +--------------------------------------SUBJ:V-N-------------------------------------+                         
                       |                                +------------OBJ:V-N------------+                                                   +-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            +---MOD_ATT:N-ADJ---+         +MOD_ATT:N-ADJ+       |                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,endproducts)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,endproducts)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 15

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                                +--------------------------------------SUBJ:V-N-------------------------------------+                         
                       |                                +------------OBJ:V-N------------+                   +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            +---MOD_ATT:N-ADJ---+         +MOD_ATT:N-ADJ+       |                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,endproducts)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,endproducts)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 16

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                                +--------------------------------------SUBJ:V-N-------------------------------------+                         
                       |                                +------------OBJ:V-N------------+                   +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            +---MOD_ATT:N-ADJ---+         +MOD_ATT:N-ADJ+       |                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,endproducts)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,endproducts)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 17

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               |                                +--------------------------------------SUBJ:V-N-------------------------------------+                         
       |               |                                +------------OBJ:V-N------------+                                                   +-------OBJ:V-N-------+   
       |               |            +---MOD_ATT:N-ADJ---+         +MOD_ATT:N-ADJ+       |                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,endproducts)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,endproducts)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 18

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               |                                +--------------------------------------SUBJ:V-N-------------------------------------+                         
       |               |                                +------------OBJ:V-N------------+                   +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       |               |            +---MOD_ATT:N-ADJ---+         +MOD_ATT:N-ADJ+       |                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,endproducts)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,endproducts)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 19

                                                                                                                        +---------------COMP:N-N(of)--------------+   
                                                                                                                        |           +--------MOD_ATT:N-ADJ--------+   
                                                        +----------------------OBJ:V-N----------------------+           |           |       +----MOD_ATT:N-ADJ----+   
       +-MOD_ATT:N-ADJ-+----------COMP:V-N(In)----------+----OBJ:V-N----+----OBJ:V-N----+                   |           |           |       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+-SUBJ:V-N-+         +MOD_A+       +SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
COMP:V-N(In) (endproducts,fibroblast)
SUBJ:V-N (endproducts,glycation)
OBJ:V-N (endproducts,serum)
OBJ:V-N (endproducts,change)
MOD_ATT:N-ADJ (serum,__SP__)
OBJ:V-N (cause,serum)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 20

                                                                                                            +---------------------COMP:N-N(of)--------------------+   
                                                                                                            |                       +--------MOD_ATT:N-ADJ--------+   
                                                        +----------------------OBJ:V-N----------------------+                       |       +----MOD_ATT:N-ADJ----+   
       +-MOD_ATT:N-ADJ-+----------COMP:V-N(In)----------+----OBJ:V-N----+----OBJ:V-N----+                   |                       |       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+-SUBJ:V-N-+         +MOD_A+       +SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
COMP:V-N(In) (endproducts,fibroblast)
SUBJ:V-N (endproducts,glycation)
OBJ:V-N (endproducts,serum)
OBJ:V-N (endproducts,change)
MOD_ATT:N-ADJ (serum,__SP__)
OBJ:V-N (cause,serum)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 21

                                                                                                                        +---------------COMP:N-N(of)--------------+   
                                                                                                                        |           +--------MOD_ATT:N-ADJ--------+   
                                                        +----------------------OBJ:V-N----------------------+           |           |       +----MOD_ATT:N-ADJ----+   
       +-MOD_ATT:N-ADJ-+----------COMP:V-N(In)----------+         +-------OBJ:V-N-------+                   |           |           |       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+-SUBJ:V-N-+-OBJ:V-N-+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
COMP:V-N(In) (endproducts,fibroblast)
SUBJ:V-N (endproducts,glycation)
OBJ:V-N (endproducts,__SP__)
OBJ:V-N (endproducts,change)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 22

                                                                                                            +---------------------COMP:N-N(of)--------------------+   
                                                                                                            |                       +--------MOD_ATT:N-ADJ--------+   
                                                        +----------------------OBJ:V-N----------------------+                       |       +----MOD_ATT:N-ADJ----+   
       +-MOD_ATT:N-ADJ-+----------COMP:V-N(In)----------+         +-------OBJ:V-N-------+                   |                       |       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+-SUBJ:V-N-+-OBJ:V-N-+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
COMP:V-N(In) (endproducts,fibroblast)
SUBJ:V-N (endproducts,glycation)
OBJ:V-N (endproducts,__SP__)
OBJ:V-N (endproducts,change)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 23

                                                                                                                        +---------------COMP:N-N(of)--------------+   
                                                                                                                        |           +--------MOD_ATT:N-ADJ--------+   
                       +---------------COMP:V-N(In)---------------+-----------------OBJ:V-N-----------------+           |           |       +----MOD_ATT:N-ADJ----+   
       +-MOD_ATT:N-ADJ-+            +---MOD_ATT:N-ADJ---+         |     +----OBJ:V-N----+                   |           |           |       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+-SUBJ:V-N+OBJ:V+       +SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
COMP:V-N(In) (__SP__,fibroblast)
SUBJ:V-N (__SP__,endproducts)
OBJ:V-N (__SP__,serum)
OBJ:V-N (__SP__,change)
OBJ:V-N (cause,serum)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 24

                                                                                                                        +---------------COMP:N-N(of)--------------+   
                                                                                                                        |           +--------MOD_ATT:N-ADJ--------+   
                       +---------------COMP:V-N(In)---------------+-----------------OBJ:V-N-----------------+           |           |       +----MOD_ATT:N-ADJ----+   
       +-MOD_ATT:N-ADJ-+            +---MOD_ATT:N-ADJ---+         |     +----OBJ:V-N----+                   |           |           |       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+-SUBJ:V-N+OBJ:V+       +SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
COMP:V-N(In) (__SP__,fibroblast)
SUBJ:V-N (__SP__,endproducts)
OBJ:V-N (__SP__,serum)
OBJ:V-N (__SP__,change)
OBJ:V-N (cause,serum)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 25

                                                                                                            +---------------------COMP:N-N(of)--------------------+   
                                                                                                            |                       +--------MOD_ATT:N-ADJ--------+   
                       +---------------COMP:V-N(In)---------------+-----------------OBJ:V-N-----------------+                       |       +----MOD_ATT:N-ADJ----+   
       +-MOD_ATT:N-ADJ-+            +---MOD_ATT:N-ADJ---+         |     +----OBJ:V-N----+                   |                       |       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+-SUBJ:V-N+OBJ:V+       +SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
COMP:V-N(In) (__SP__,fibroblast)
SUBJ:V-N (__SP__,endproducts)
OBJ:V-N (__SP__,serum)
OBJ:V-N (__SP__,change)
OBJ:V-N (cause,serum)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 26

                                                                                                            +---------------------COMP:N-N(of)--------------------+   
                                                                                                            |                       +--------MOD_ATT:N-ADJ--------+   
                       +---------------COMP:V-N(In)---------------+-----------------OBJ:V-N-----------------+                       |       +----MOD_ATT:N-ADJ----+   
       +-MOD_ATT:N-ADJ-+            +---MOD_ATT:N-ADJ---+         |     +----OBJ:V-N----+                   |                       |       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+-SUBJ:V-N+OBJ:V+       +SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
COMP:V-N(In) (__SP__,fibroblast)
SUBJ:V-N (__SP__,endproducts)
OBJ:V-N (__SP__,serum)
OBJ:V-N (__SP__,change)
OBJ:V-N (cause,serum)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 27

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               |                                +--------------------------------------SUBJ:V-N-------------------------------------+                         
       |               |                                +------------OBJ:V-N------------+                                                   +-------OBJ:V-N-------+   
       |               |            +---MOD_ATT:N-ADJ---+         +MOD_ATT:N-ADJ+       |                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,endproducts)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,endproducts)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 28

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               |                                +--------------------------------------SUBJ:V-N-------------------------------------+                         
       |               |                                +------------OBJ:V-N------------+                   +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       |               |            +---MOD_ATT:N-ADJ---+         +MOD_ATT:N-ADJ+       |                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,endproducts)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,endproducts)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 29

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                                +--------------------------------------SUBJ:V-N-------------------------------------+                         
                       |                                +------------OBJ:V-N------------+                                                   +-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            +---MOD_ATT:N-ADJ---+         +MOD_ATT:N-ADJ+       |                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,endproducts)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,endproducts)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 30

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                                +--------------------------------------SUBJ:V-N-------------------------------------+                         
                       |                                +------------OBJ:V-N------------+                   +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            +---MOD_ATT:N-ADJ---+         +MOD_ATT:N-ADJ+       |                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,endproducts)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,endproducts)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 31

                                                                                                                        +---------------COMP:N-N(of)--------------+   
                                                                        +------------------COMP:N-N(in)-----------------+           +--------MOD_ATT:N-ADJ--------+   
                       +---------------COMP:V-N(In)---------------+-----------------OBJ:V-N-----------------+           |           |       +----MOD_ATT:N-ADJ----+   
       +-MOD_ATT:N-ADJ-+            +---MOD_ATT:N-ADJ---+         |     +----OBJ:V-N----+                   |           |           |       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+-SUBJ:V-N+OBJ:V+       +SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
COMP:V-N(In) (__SP__,fibroblast)
SUBJ:V-N (__SP__,endproducts)
OBJ:V-N (__SP__,serum)
OBJ:V-N (__SP__,change)
COMP:N-N(in) (serum,expression)
OBJ:V-N (cause,serum)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 32

                                                                                                                        +---------------COMP:N-N(of)--------------+   
                                                                        +------------------COMP:N-N(in)-----------------+           +--------MOD_ATT:N-ADJ--------+   
                       +---------------COMP:V-N(In)---------------+-----------------OBJ:V-N-----------------+           |           |       +----MOD_ATT:N-ADJ----+   
       +-MOD_ATT:N-ADJ-+            +---MOD_ATT:N-ADJ---+         |     +----OBJ:V-N----+                   |           |           |       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+-SUBJ:V-N+OBJ:V+       +SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
COMP:V-N(In) (__SP__,fibroblast)
SUBJ:V-N (__SP__,endproducts)
OBJ:V-N (__SP__,serum)
OBJ:V-N (__SP__,change)
COMP:N-N(in) (serum,expression)
OBJ:V-N (cause,serum)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 33

                                                                        +---------------------------------------COMP:N-N(of)--------------------------------------+   
                                                                        |                                   +---------------------COMP:N-N(of)--------------------+   
                                                                        +------------------COMP:N-N(in)-----------------+           +--------MOD_ATT:N-ADJ--------+   
                       +---------------COMP:V-N(In)---------------+-----------------OBJ:V-N-----------------+           |           |       +----MOD_ATT:N-ADJ----+   
       +-MOD_ATT:N-ADJ-+            +---MOD_ATT:N-ADJ---+         |     +----OBJ:V-N----+                   |           |           |       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+-SUBJ:V-N+OBJ:V+       +SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
COMP:V-N(In) (__SP__,fibroblast)
SUBJ:V-N (__SP__,endproducts)
OBJ:V-N (__SP__,serum)
OBJ:V-N (__SP__,change)
COMP:N-N(in) (serum,expression)
COMP:N-N(of) (serum,mRNA)
OBJ:V-N (cause,serum)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 34

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |            +--------MOD_ATT:N-ADJ--------+---------------------------------SUBJ:V-N--------------------------------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 35

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |            +--------MOD_ATT:N-ADJ--------+---------------------------------SUBJ:V-N--------------------------------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 36

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                                          +---------------------------------SUBJ:V-N--------------------------------+                         
                       |            +--------MOD_ATT:N-ADJ--------+                                         +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 37

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                                          +---------------------------------SUBJ:V-N--------------------------------+                         
                       |            +--------MOD_ATT:N-ADJ--------+                                         +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 38

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                                          +---------------------------------SUBJ:V-N--------------------------------+                         
                       |            +--------MOD_ATT:N-ADJ--------+                                         +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 39

                                                                                                                        +---------------COMP:N-N(of)--------------+   
                                                        +----------------------OBJ:V-N----------------------+           |           +--------MOD_ATT:N-ADJ--------+   
                                                        |               +------------------COMP:N-N(in)-----------------+           |       +----MOD_ATT:N-ADJ----+   
       +-MOD_ATT:N-ADJ-+----------COMP:V-N(In)----------+----OBJ:V-N----+----OBJ:V-N----+                   |           |           |       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+-SUBJ:V-N-+         +MOD_A+       +SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
COMP:V-N(In) (endproducts,fibroblast)
SUBJ:V-N (endproducts,glycation)
OBJ:V-N (endproducts,serum)
OBJ:V-N (endproducts,change)
MOD_ATT:N-ADJ (serum,__SP__)
COMP:N-N(in) (serum,expression)
OBJ:V-N (cause,serum)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 40

                                                                                                                        +---------------COMP:N-N(of)--------------+   
                                                                  +---------------------COMP:N-N(in)--------------------+           +--------MOD_ATT:N-ADJ--------+   
                                                        +----------------------OBJ:V-N----------------------+           |           |       +----MOD_ATT:N-ADJ----+   
       +-MOD_ATT:N-ADJ-+----------COMP:V-N(In)----------+         +-------OBJ:V-N-------+                   |           |           |       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+-SUBJ:V-N-+-OBJ:V-N-+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
COMP:V-N(In) (endproducts,fibroblast)
SUBJ:V-N (endproducts,glycation)
OBJ:V-N (endproducts,__SP__)
OBJ:V-N (endproducts,change)
COMP:N-N(in) (__SP__,expression)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 41

                                                                        +---------------------------------------COMP:N-N(of)--------------------------------------+   
                                                                        |                                   +---------------------COMP:N-N(of)--------------------+   
                                                        +----------------------OBJ:V-N----------------------+                       +--------MOD_ATT:N-ADJ--------+   
                                                        |               +------------------COMP:N-N(in)-----------------+           |       +----MOD_ATT:N-ADJ----+   
       +-MOD_ATT:N-ADJ-+----------COMP:V-N(In)----------+----OBJ:V-N----+----OBJ:V-N----+                   |           |           |       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+-SUBJ:V-N-+         +MOD_A+       +SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
COMP:V-N(In) (endproducts,fibroblast)
SUBJ:V-N (endproducts,glycation)
OBJ:V-N (endproducts,serum)
OBJ:V-N (endproducts,change)
MOD_ATT:N-ADJ (serum,__SP__)
COMP:N-N(in) (serum,expression)
COMP:N-N(of) (serum,mRNA)
OBJ:V-N (cause,serum)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 42

                                                                        +---------------------------------------COMP:N-N(of)--------------------------------------+   
                                                                        |                                   +---------------------COMP:N-N(of)--------------------+   
                                                        +----------------------OBJ:V-N----------------------+                       +--------MOD_ATT:N-ADJ--------+   
                                                        |               +------------------COMP:N-N(in)-----------------+           |       +----MOD_ATT:N-ADJ----+   
       +-MOD_ATT:N-ADJ-+----------COMP:V-N(In)----------+----OBJ:V-N----+----OBJ:V-N----+                   |           |           |       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+-SUBJ:V-N-+         +MOD_A+       +SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
COMP:V-N(In) (endproducts,fibroblast)
SUBJ:V-N (endproducts,glycation)
OBJ:V-N (endproducts,serum)
OBJ:V-N (endproducts,change)
MOD_ATT:N-ADJ (serum,__SP__)
COMP:N-N(in) (serum,expression)
COMP:N-N(of) (serum,mRNA)
OBJ:V-N (cause,serum)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 43

                                                                  +------------------------------------------COMP:N-N(of)-----------------------------------------+   
                                                                  +---------------------COMP:N-N(in)--------------------+                                         |   
                                                                  |                                         +---------------------COMP:N-N(of)--------------------+   
                                                                  |                                         |           |           +--------MOD_ATT:N-ADJ--------+   
                                                        +----------------------OBJ:V-N----------------------+           |           |       +----MOD_ATT:N-ADJ----+   
       +-MOD_ATT:N-ADJ-+----------COMP:V-N(In)----------+         +-------OBJ:V-N-------+                   |           |           |       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+-SUBJ:V-N-+-OBJ:V-N-+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
COMP:V-N(In) (endproducts,fibroblast)
SUBJ:V-N (endproducts,glycation)
OBJ:V-N (endproducts,__SP__)
OBJ:V-N (endproducts,change)
COMP:N-N(in) (__SP__,expression)
COMP:N-N(of) (__SP__,mRNA)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 44

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               |            +--------MOD_ATT:N-ADJ--------+---------------------------------SUBJ:V-N--------------------------------+-------OBJ:V-N-------+   
       |               |            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 45

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               |                                          +---------------------------------SUBJ:V-N--------------------------------+                         
       |               |            +--------MOD_ATT:N-ADJ--------+                                         +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       |               |            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 46

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               +------------------------------------------COMP:N-N(in)------------------------------------------+                   |                         
       |               |                                +--------------------------------------SUBJ:V-N-------------------------------------+                         
       |               |                                +--------------------------COMP:N-N(in)-------------------------+                   |                         
       |               |                                +------------OBJ:V-N------------+                               |                   +-------OBJ:V-N-------+   
       |               |            +---MOD_ATT:N-ADJ---+         +MOD_ATT:N-ADJ+       |                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
COMP:N-N(in) (fibroblast,expression)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
COMP:N-N(in) (endproducts,expression)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,endproducts)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,endproducts)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 47

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               +------------------------------------------------COMP:N-N(of)------------------------------------------------+       |                         
       |               +------------------------------------------COMP:N-N(in)------------------------------------------+           |       |                         
       |               |                                +--------------------------------------SUBJ:V-N-------------------------------------+                         
       |               |                                +--------------------------------COMP:N-N(of)-------------------------------+       |                         
       |               |                                +--------------------------COMP:N-N(in)-------------------------+           |       |                         
       |               |                                +------------OBJ:V-N------------+                   +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       |               |            +---MOD_ATT:N-ADJ---+         +MOD_ATT:N-ADJ+       |                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
COMP:N-N(in) (fibroblast,expression)
COMP:N-N(of) (fibroblast,__SP__)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
COMP:N-N(in) (endproducts,expression)
COMP:N-N(of) (endproducts,__SP__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,endproducts)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,endproducts)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 48

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               |            +--------MOD_ATT:N-ADJ--------+---------------------------------SUBJ:V-N--------------------------------+-------OBJ:V-N-------+   
       |               |            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 49

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               +------------------------------------------COMP:N-N(in)------------------------------------------+                   |                         
       |               |                                +--------------------------------------SUBJ:V-N-------------------------------------+                         
       |               |                                +--------------------------COMP:N-N(in)-------------------------+                   |                         
       |               |                                +------------OBJ:V-N------------+                               |                   +-------OBJ:V-N-------+   
       |               |            +---MOD_ATT:N-ADJ---+         +MOD_ATT:N-ADJ+       |                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
COMP:N-N(in) (fibroblast,expression)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
COMP:N-N(in) (endproducts,expression)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,endproducts)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,endproducts)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 50

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               |                                          +---------------------------------SUBJ:V-N--------------------------------+                         
       |               |            +--------MOD_ATT:N-ADJ--------+                                         +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       |               |            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 51

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                                +--------------------------------------SUBJ:V-N-------------------------------------+                         
                       |                                +--------------------------COMP:N-N(in)-------------------------+                   |                         
                       |                                +------------OBJ:V-N------------+                               |                   +-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            +---MOD_ATT:N-ADJ---+         +MOD_ATT:N-ADJ+       |                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
COMP:N-N(in) (endproducts,expression)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,endproducts)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,endproducts)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 52

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                                +--------------------------------------SUBJ:V-N-------------------------------------+                         
                       |                                +--------------------------COMP:N-N(in)-------------------------+                   |                         
                       |                                +------------OBJ:V-N------------+                               |                   +-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            +---MOD_ATT:N-ADJ---+         +MOD_ATT:N-ADJ+       |                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
COMP:N-N(in) (endproducts,expression)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,endproducts)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,endproducts)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 53

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               +------------------------------------------------COMP:N-N(of)------------------------------------------------+       |                         
       |               +------------------------------------------COMP:N-N(in)------------------------------------------+           |       |                         
       |               |                                +--------------------------------------SUBJ:V-N-------------------------------------+                         
       |               |                                +--------------------------------COMP:N-N(of)-------------------------------+       |                         
       |               |                                +--------------------------COMP:N-N(in)-------------------------+           |       |                         
       |               |                                +------------OBJ:V-N------------+                   +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       |               |            +---MOD_ATT:N-ADJ---+         +MOD_ATT:N-ADJ+       |                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
COMP:N-N(in) (fibroblast,expression)
COMP:N-N(of) (fibroblast,__SP__)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
COMP:N-N(in) (endproducts,expression)
COMP:N-N(of) (endproducts,__SP__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,endproducts)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,endproducts)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 54

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                                +--------------------------------------SUBJ:V-N-------------------------------------+                         
                       |                                +--------------------------------COMP:N-N(of)-------------------------------+       |                         
                       |                                +--------------------------COMP:N-N(in)-------------------------+           |       |                         
                       |                                +------------OBJ:V-N------------+                   +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            +---MOD_ATT:N-ADJ---+         +MOD_ATT:N-ADJ+       |                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
COMP:N-N(in) (endproducts,expression)
COMP:N-N(of) (endproducts,__SP__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,endproducts)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,endproducts)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 55

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |            +--------MOD_ATT:N-ADJ--------+---------------------------------SUBJ:V-N--------------------------------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 56

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |            +--------MOD_ATT:N-ADJ--------+---------------------------------SUBJ:V-N--------------------------------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 57

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |            +--------MOD_ATT:N-ADJ--------+---------------------------------SUBJ:V-N--------------------------------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 58

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                                          +---------------------------------SUBJ:V-N--------------------------------+                         
                       |            +--------MOD_ATT:N-ADJ--------+                                         +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 59

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                                          +---------------------------------SUBJ:V-N--------------------------------+                         
                       |            +--------MOD_ATT:N-ADJ--------+                                         +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 60

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                                +--------------------------------------SUBJ:V-N-------------------------------------+                         
                       |                                +--------------------------COMP:N-N(in)-------------------------+                   |                         
                       |                                +------------OBJ:V-N------------+                               |                   +-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            +---MOD_ATT:N-ADJ---+         +MOD_ATT:N-ADJ+       |                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
COMP:N-N(in) (endproducts,expression)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,endproducts)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,endproducts)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 61

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                                +--------------------------------------SUBJ:V-N-------------------------------------+                         
                       |                                +--------------------------------COMP:N-N(of)-------------------------------+       |                         
                       |                                +--------------------------COMP:N-N(in)-------------------------+           |       |                         
                       |                                +------------OBJ:V-N------------+                   +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            +---MOD_ATT:N-ADJ---+         +MOD_ATT:N-ADJ+       |                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
COMP:N-N(in) (endproducts,expression)
COMP:N-N(of) (endproducts,__SP__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,endproducts)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,endproducts)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 62

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                                +--------------------------------------SUBJ:V-N-------------------------------------+                         
                       |                                +--------------------------------COMP:N-N(of)-------------------------------+       |                         
                       |                                +--------------------------COMP:N-N(in)-------------------------+           |       |                         
                       |                                +------------OBJ:V-N------------+                   +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            +---MOD_ATT:N-ADJ---+         +MOD_ATT:N-ADJ+       |                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        +MOD_ATT:N-+         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (endproducts,advanced)
MOD_ATT:N-N (endproducts,glycation)
COMP:N-N(in) (endproducts,expression)
COMP:N-N(of) (endproducts,__SP__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,endproducts)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,endproducts)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 63

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
                       |                     +------------------OBJ:V-N-----------------+                                                   |                         
                       |                     |          +------MOD_ATT:N-N------+       |                                                   +-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+                     |          |         +MOD_ATT:N-ADJ+       |                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 64

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
                       |                     +------------------OBJ:V-N-----------------+                                                   |                         
                       |                     |          +------MOD_ATT:N-N------+       |                                                   +-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+                     |          |         +MOD_ATT:N-ADJ+       |                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 65

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
                       |                     +------------------OBJ:V-N-----------------+                                                   |                         
                       |                     |          +------MOD_ATT:N-N------+       |                                                   +-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+                     |          |         +MOD_ATT:N-ADJ+       |                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 66

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
                       |                     +------------------OBJ:V-N-----------------+                                                   |                         
                       |                     |          +------MOD_ATT:N-N------+       |                   +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+                     |          |         +MOD_ATT:N-ADJ+       |                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 67

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
                       |                     +------------------OBJ:V-N-----------------+                                                   |                         
                       |                     |          +------MOD_ATT:N-N------+       |                   +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+                     |          |         +MOD_ATT:N-ADJ+       |                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 68

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
       |               |                     +------------------OBJ:V-N-----------------+                                                   |                         
       |               |                     |          +------MOD_ATT:N-N------+       |                                                   +-------OBJ:V-N-------+   
       |               |                     |          |         +MOD_ATT:N-ADJ+       |                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 69

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
       |               |                     +------------------OBJ:V-N-----------------+                                                   |                         
       |               |                     |          +------MOD_ATT:N-N------+       |                   +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       |               |                     |          |         +MOD_ATT:N-ADJ+       |                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 70

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               +------------------------------------------COMP:N-N(in)------------------------------------------+                   |                         
       |               |                                          +---------------------------------SUBJ:V-N--------------------------------+                         
       |               |            +--------MOD_ATT:N-ADJ--------+---------------------COMP:N-N(in)--------------------+                   +-------OBJ:V-N-------+   
       |               |            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
COMP:N-N(in) (fibroblast,expression)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
COMP:N-N(in) (__SP__,expression)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 71

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               +------------------------------------------COMP:N-N(in)------------------------------------------+                   |                         
       |               |                                          +---------------------------------SUBJ:V-N--------------------------------+                         
       |               |            +--------MOD_ATT:N-ADJ--------+---------------------COMP:N-N(in)--------------------+                   +-------OBJ:V-N-------+   
       |               |            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
COMP:N-N(in) (fibroblast,expression)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
COMP:N-N(in) (__SP__,expression)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 72

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               +------------------------------------------------COMP:N-N(of)------------------------------------------------+       |                         
       |               +------------------------------------------COMP:N-N(in)------------------------------------------+           |       |                         
       |               |                                          +---------------------------------SUBJ:V-N--------------------------------+                         
       |               |                                          +---------------------------COMP:N-N(of)--------------------------+       |                         
       |               |                                          +---------------------COMP:N-N(in)--------------------+           |       |                         
       |               |            +--------MOD_ATT:N-ADJ--------+                                         +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       |               |            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
COMP:N-N(in) (fibroblast,expression)
COMP:N-N(of) (fibroblast,__SP__)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
COMP:N-N(in) (__SP__,expression)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 73

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               +------------------------------------------------COMP:N-N(of)------------------------------------------------+       |                         
       |               +------------------------------------------COMP:N-N(in)------------------------------------------+           |       |                         
       |               |                                          +---------------------------------SUBJ:V-N--------------------------------+                         
       |               |                                          +---------------------------COMP:N-N(of)--------------------------+       |                         
       |               |                                          +---------------------COMP:N-N(in)--------------------+           |       |                         
       |               |            +--------MOD_ATT:N-ADJ--------+                                         +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       |               |            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
COMP:N-N(in) (fibroblast,expression)
COMP:N-N(of) (fibroblast,__SP__)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
COMP:N-N(in) (__SP__,expression)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 74

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                                          +---------------------------------SUBJ:V-N--------------------------------+                         
                       |            +--------MOD_ATT:N-ADJ--------+---------------------COMP:N-N(in)--------------------+                   +-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
COMP:N-N(in) (__SP__,expression)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 75

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                                          +---------------------------------SUBJ:V-N--------------------------------+                         
                       |            +--------MOD_ATT:N-ADJ--------+---------------------COMP:N-N(in)--------------------+                   +-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
COMP:N-N(in) (__SP__,expression)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 76

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                                          +---------------------------------SUBJ:V-N--------------------------------+                         
                       |            +--------MOD_ATT:N-ADJ--------+---------------------COMP:N-N(in)--------------------+                   +-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
COMP:N-N(in) (__SP__,expression)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 77

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               +------------------------------------------COMP:N-N(in)------------------------------------------+                   |                         
       |               |                                          +---------------------------------SUBJ:V-N--------------------------------+                         
       |               |            +--------MOD_ATT:N-ADJ--------+---------------------COMP:N-N(in)--------------------+                   +-------OBJ:V-N-------+   
       |               |            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
COMP:N-N(in) (fibroblast,expression)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
COMP:N-N(in) (__SP__,expression)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 78

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               +------------------------------------------COMP:N-N(in)------------------------------------------+                   |                         
       |               |                                          +---------------------------------SUBJ:V-N--------------------------------+                         
       |               |            +--------MOD_ATT:N-ADJ--------+---------------------COMP:N-N(in)--------------------+                   +-------OBJ:V-N-------+   
       |               |            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
COMP:N-N(in) (fibroblast,expression)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
COMP:N-N(in) (__SP__,expression)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 79

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
       |               |                     +------------------OBJ:V-N-----------------+                                                   |                         
       |               |                     |          +------MOD_ATT:N-N------+       |                                                   +-------OBJ:V-N-------+   
       |               |                     |          |         +MOD_ATT:N-ADJ+       |                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 80

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
       |               |                     +------------------OBJ:V-N-----------------+                                                   |                         
       |               |                     |          +------MOD_ATT:N-N------+       |                                                   +-------OBJ:V-N-------+   
       |               |                     |          |         +MOD_ATT:N-ADJ+       |                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 81

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
       |               |                     +------------------OBJ:V-N-----------------+                                                   |                         
       |               |                     |          +------MOD_ATT:N-N------+       |                   +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       |               |                     |          |         +MOD_ATT:N-ADJ+       |                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 82

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
       |               |                     +------------------OBJ:V-N-----------------+                                                   |                         
       |               |                     |          +------MOD_ATT:N-N------+       |                   +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       |               |                     |          |         +MOD_ATT:N-ADJ+       |                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 83

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                                          +---------------------------------SUBJ:V-N--------------------------------+                         
                       |                                          +---------------------------COMP:N-N(of)--------------------------+       |                         
                       |                                          +---------------------COMP:N-N(in)--------------------+           |       |                         
                       |            +--------MOD_ATT:N-ADJ--------+                                         +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
COMP:N-N(in) (__SP__,expression)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 84

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                                          +---------------------------------SUBJ:V-N--------------------------------+                         
                       |                                          +---------------------------COMP:N-N(of)--------------------------+       |                         
                       |                                          +---------------------COMP:N-N(in)--------------------+           |       |                         
                       |            +--------MOD_ATT:N-ADJ--------+                                         +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
COMP:N-N(in) (__SP__,expression)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 85

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                                          +---------------------------------SUBJ:V-N--------------------------------+                         
                       |                                          +---------------------------COMP:N-N(of)--------------------------+       |                         
                       |                                          +---------------------COMP:N-N(in)--------------------+           |       |                         
                       |            +--------MOD_ATT:N-ADJ--------+                                         +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
COMP:N-N(in) (__SP__,expression)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 86

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                                          +---------------------------------SUBJ:V-N--------------------------------+                         
                       |                                          +---------------------------COMP:N-N(of)--------------------------+       |                         
                       |                                          +---------------------COMP:N-N(in)--------------------+           |       |                         
                       |            +--------MOD_ATT:N-ADJ--------+                                         +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
COMP:N-N(in) (__SP__,expression)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 87

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               +------------------------------------------------COMP:N-N(of)------------------------------------------------+       |                         
       |               +------------------------------------------COMP:N-N(in)------------------------------------------+           |       |                         
       |               |                                          +---------------------------------SUBJ:V-N--------------------------------+                         
       |               |                                          +---------------------------COMP:N-N(of)--------------------------+       |                         
       |               |                                          +---------------------COMP:N-N(in)--------------------+           |       |                         
       |               |            +--------MOD_ATT:N-ADJ--------+                                         +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       |               |            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
COMP:N-N(in) (fibroblast,expression)
COMP:N-N(of) (fibroblast,__SP__)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
COMP:N-N(in) (__SP__,expression)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 88

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               +------------------------------------------------COMP:N-N(of)------------------------------------------------+       |                         
       |               +------------------------------------------COMP:N-N(in)------------------------------------------+           |       |                         
       |               |                                          +---------------------------------SUBJ:V-N--------------------------------+                         
       |               |                                          +---------------------------COMP:N-N(of)--------------------------+       |                         
       |               |                                          +---------------------COMP:N-N(in)--------------------+           |       |                         
       |               |            +--------MOD_ATT:N-ADJ--------+                                         +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       |               |            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
COMP:N-N(in) (fibroblast,expression)
COMP:N-N(of) (fibroblast,__SP__)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
COMP:N-N(in) (__SP__,expression)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 89

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
                       |                     +------------------OBJ:V-N-----------------+                                                   |                         
                       |                     |          +------MOD_ATT:N-N------+       |                                                   +-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+                     |          |         +MOD_ATT:N-ADJ+       |                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 90

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
                       |                     +------------------OBJ:V-N-----------------+                                                   |                         
                       |                     |          +------MOD_ATT:N-N------+       |                                                   +-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+                     |          |         +MOD_ATT:N-ADJ+       |                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 91

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
                       |                     +------------------OBJ:V-N-----------------+                                                   |                         
                       |                     |          +------MOD_ATT:N-N------+       |                   +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+                     |          |         +MOD_ATT:N-ADJ+       |                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 92

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
                       |                     +------------------OBJ:V-N-----------------+                                                   |                         
                       |                     |          +------MOD_ATT:N-N------+       |                   +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+                     |          |         +MOD_ATT:N-ADJ+       |                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 93

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
                       |                     +------------------OBJ:V-N-----------------+                                                   |                         
                       |                     |          +------MOD_ATT:N-N------+       |                   +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+                     |          |         +MOD_ATT:N-ADJ+       |                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 94

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
                       |                     +------------------OBJ:V-N-----------------+                                                   |                         
                       |                     |          +------MOD_ATT:N-N------+       |                   +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+                     |          |         +MOD_ATT:N-ADJ+       |                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 95

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                                          +---------------------------------SUBJ:V-N--------------------------------+                         
                       |            +--------MOD_ATT:N-ADJ--------+---------------------COMP:N-N(in)--------------------+                   +-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
COMP:N-N(in) (__SP__,expression)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 96

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                                          +---------------------------------SUBJ:V-N--------------------------------+                         
                       |            +--------MOD_ATT:N-ADJ--------+---------------------COMP:N-N(in)--------------------+                   +-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
COMP:N-N(in) (__SP__,expression)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 97

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                                          +---------------------------------SUBJ:V-N--------------------------------+                         
                       |            +--------MOD_ATT:N-ADJ--------+---------------------COMP:N-N(in)--------------------+                   +-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
COMP:N-N(in) (__SP__,expression)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 98

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                                          +---------------------------------SUBJ:V-N--------------------------------+                         
                       |                                          +---------------------------COMP:N-N(of)--------------------------+       |                         
                       |                                          +---------------------COMP:N-N(in)--------------------+           |       |                         
                       |            +--------MOD_ATT:N-ADJ--------+                                         +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
COMP:N-N(in) (__SP__,expression)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 99

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                                          +---------------------------------SUBJ:V-N--------------------------------+                         
                       |                                          +---------------------------COMP:N-N(of)--------------------------+       |                         
                       |                                          +---------------------COMP:N-N(in)--------------------+           |       |                         
                       |            +--------MOD_ATT:N-ADJ--------+                                         +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+            |        +-----MOD_ATT:N-N----+-------OBJ:V-N-------+                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            |        |          +MOD_ATT:N+     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (__SP__,advanced)
MOD_ATT:N-N (__SP__,glycation)
MOD_ATT:N-N (__SP__,endproducts)
COMP:N-N(in) (__SP__,expression)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,__SP__)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,__SP__)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 100

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               +------------------------------------------COMP:N-N(in)------------------------------------------+                   |                         
       |               |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
       |               |                     +-------------------------------COMP:N-N(in)-------------------------------+                   |                         
       |               |                     +------------------OBJ:V-N-----------------+                               |                   |                         
       |               |                     |          +------MOD_ATT:N-N------+       |                               |                   +-------OBJ:V-N-------+   
       |               |                     |          |         +MOD_ATT:N-ADJ+       |                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
COMP:N-N(in) (fibroblast,expression)
MOD_ATT:N-ADJ (glycation,advanced)
COMP:N-N(in) (glycation,expression)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 101

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               +------------------------------------------------COMP:N-N(of)------------------------------------------------+       |                         
       |               +------------------------------------------COMP:N-N(in)------------------------------------------+           |       |                         
       |               |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
       |               |                     +-------------------------------------COMP:N-N(of)-------------------------------------+       |                         
       |               |                     +-------------------------------COMP:N-N(in)-------------------------------+           |       |                         
       |               |                     +------------------OBJ:V-N-----------------+                               |           |       |                         
       |               |                     |          +------MOD_ATT:N-N------+       |                   +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       |               |                     |          |         +MOD_ATT:N-ADJ+       |                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
COMP:N-N(in) (fibroblast,expression)
COMP:N-N(of) (fibroblast,__SP__)
MOD_ATT:N-ADJ (glycation,advanced)
COMP:N-N(in) (glycation,expression)
COMP:N-N(of) (glycation,__SP__)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 102

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               +------------------------------------------COMP:N-N(in)------------------------------------------+                   |                         
       |               |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
       |               |                     +-------------------------------COMP:N-N(in)-------------------------------+                   |                         
       |               |                     +------------------OBJ:V-N-----------------+                               |                   |                         
       |               |                     |          +------MOD_ATT:N-N------+       |                               |                   +-------OBJ:V-N-------+   
       |               |                     |          |         +MOD_ATT:N-ADJ+       |                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
COMP:N-N(in) (fibroblast,expression)
MOD_ATT:N-ADJ (glycation,advanced)
COMP:N-N(in) (glycation,expression)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 103

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
                       |                     +-------------------------------COMP:N-N(in)-------------------------------+                   |                         
                       |                     +------------------OBJ:V-N-----------------+                               |                   |                         
                       |                     |          +------MOD_ATT:N-N------+       |                               |                   +-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+                     |          |         +MOD_ATT:N-ADJ+       |                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
COMP:N-N(in) (glycation,expression)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 104

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
                       |                     +-------------------------------COMP:N-N(in)-------------------------------+                   |                         
                       |                     +------------------OBJ:V-N-----------------+                               |                   |                         
                       |                     |          +------MOD_ATT:N-N------+       |                               |                   +-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+                     |          |         +MOD_ATT:N-ADJ+       |                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
COMP:N-N(in) (glycation,expression)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 105

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               +------------------------------------------------COMP:N-N(of)------------------------------------------------+       |                         
       |               +------------------------------------------COMP:N-N(in)------------------------------------------+           |       |                         
       |               |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
       |               |                     +-------------------------------------COMP:N-N(of)-------------------------------------+       |                         
       |               |                     +-------------------------------COMP:N-N(in)-------------------------------+           |       |                         
       |               |                     +------------------OBJ:V-N-----------------+                               |           |       |                         
       |               |                     |          +------MOD_ATT:N-N------+       |                   +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       |               |                     |          |         +MOD_ATT:N-ADJ+       |                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
COMP:N-N(in) (fibroblast,expression)
COMP:N-N(of) (fibroblast,__SP__)
MOD_ATT:N-ADJ (glycation,advanced)
COMP:N-N(in) (glycation,expression)
COMP:N-N(of) (glycation,__SP__)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 106

       +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+                         
       |               +------------------------------------------------------SUBJ:V-N------------------------------------------------------+                         
       |               +------------------------------------------------COMP:N-N(of)------------------------------------------------+       |                         
       |               +------------------------------------------COMP:N-N(in)------------------------------------------+           |       |                         
       |               |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
       |               |                     +-------------------------------------COMP:N-N(of)-------------------------------------+       |                         
       |               |                     +-------------------------------COMP:N-N(in)-------------------------------+           |       |                         
       |               |                     +------------------OBJ:V-N-----------------+                               |           |       |                         
       |               |                     |          +------MOD_ATT:N-N------+       |                   +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       |               |                     |          |         +MOD_ATT:N-ADJ+       |                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,dermal)
COMP:N-N(in) (fibroblast,expression)
COMP:N-N(of) (fibroblast,__SP__)
MOD_ATT:N-ADJ (glycation,advanced)
COMP:N-N(in) (glycation,expression)
COMP:N-N(of) (glycation,__SP__)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 107

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
                       |                     +-------------------------------------COMP:N-N(of)-------------------------------------+       |                         
                       |                     +-------------------------------COMP:N-N(in)-------------------------------+           |       |                         
                       |                     +------------------OBJ:V-N-----------------+                               |           |       |                         
                       |                     |          +------MOD_ATT:N-N------+       |                   +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+                     |          |         +MOD_ATT:N-ADJ+       |                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
COMP:N-N(in) (glycation,expression)
COMP:N-N(of) (glycation,__SP__)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 108

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
                       |                     +-------------------------------------COMP:N-N(of)-------------------------------------+       |                         
                       |                     +-------------------------------COMP:N-N(in)-------------------------------+           |       |                         
                       |                     +------------------OBJ:V-N-----------------+                               |           |       |                         
                       |                     |          +------MOD_ATT:N-N------+       |                   +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+                     |          |         +MOD_ATT:N-ADJ+       |                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
COMP:N-N(in) (glycation,expression)
COMP:N-N(of) (glycation,__SP__)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 109

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
                       |                     +-------------------------------------COMP:N-N(of)-------------------------------------+       |                         
                       |                     +-------------------------------COMP:N-N(in)-------------------------------+           |       |                         
                       |                     +------------------OBJ:V-N-----------------+                               |           |       |                         
                       |                     |          +------MOD_ATT:N-N------+       |                   +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+                     |          |         +MOD_ATT:N-ADJ+       |                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
COMP:N-N(in) (glycation,expression)
COMP:N-N(of) (glycation,__SP__)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 110

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
                       |                     +-------------------------------COMP:N-N(in)-------------------------------+                   |                         
                       |                     +------------------OBJ:V-N-----------------+                               |                   |                         
                       |                     |          +------MOD_ATT:N-N------+       |                               |                   +-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+                     |          |         +MOD_ATT:N-ADJ+       |                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
COMP:N-N(in) (glycation,expression)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 111

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
                       |                     +-------------------------------COMP:N-N(in)-------------------------------+                   |                         
                       |                     +------------------OBJ:V-N-----------------+                               |                   |                         
                       |                     |          +------MOD_ATT:N-N------+       |                               |                   +-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+                     |          |         +MOD_ATT:N-ADJ+       |                   +------------SUBJ:V-N-----------+     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
COMP:N-N(in) (glycation,expression)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 112

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
                       |                     +-------------------------------------COMP:N-N(of)-------------------------------------+       |                         
                       |                     +-------------------------------COMP:N-N(in)-------------------------------+           |       |                         
                       |                     +------------------OBJ:V-N-----------------+                               |           |       |                         
                       |                     |          +------MOD_ATT:N-N------+       |                   +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+                     |          |         +MOD_ATT:N-ADJ+       |                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
COMP:N-N(in) (glycation,expression)
COMP:N-N(of) (glycation,__SP__)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 113

                       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                         
                       |                     +-------------------------------------------SUBJ:V-N-------------------------------------------+                         
                       |                     +-------------------------------------COMP:N-N(of)-------------------------------------+       |                         
                       |                     +-------------------------------COMP:N-N(in)-------------------------------+           |       |                         
                       |                     +------------------OBJ:V-N-----------------+                               |           |       |                         
                       |                     |          +------MOD_ATT:N-N------+       |                   +------------SUBJ:V-N-----------+-------OBJ:V-N-------+   
       +-MOD_ATT:N-ADJ-+                     |          |         +MOD_ATT:N-ADJ+       |                   +------COMP:N-N(of)-----+       |     +-MOD_ATT:N-ADJ-+   
       |      +MOD_ATT:+            +MOD_ATT:+          |         |     +MOD_ATT+SUBJ:V-+MOD:V-+            +COMP:N-N(in+           |       |     |       +MOD_ATT+   
       |      |        |            |        |          |         |     |       |       |      |            |           |           |       |     |       |       |   
 In __SP__ dermal fibroblasts , advanced glycation endproducts __SP__ serum __NODE__ causes little or no change in expression of __SP__ __NODE__ rP1 [__NODE__] mRNA .
MOD_ATT:N-ADJ (fibroblast,__SP__)
MOD_ATT:N-ADJ (fibroblast,dermal)
MOD_ATT:N-ADJ (glycation,advanced)
COMP:N-N(in) (glycation,expression)
COMP:N-N(of) (glycation,__SP__)
MOD_ATT:N-N (__NODE__,endproducts)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,serum)
OBJ:V-N (cause,glycation)
SUBJ:V-N (cause,__NODE__)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,fibroblast)
SUBJ:V-N (__NODE__,glycation)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
MOD_ATT:N-ADJ (mRNA,rP1)
MOD_ATT:N-N (mRNA,[__NODE__])